Comparison of injection site reactions and flu-like symptoms between users of peginterferon beta-1a and subcutaneous interferon beta-1a among persons with multiple sclerosis in the New York State Multiple Sclerosis Consortium

被引：0
|
作者：
Vaughn, C. [1 ,2 ,3 ]
Kavak, K. [1 ,3 ]
Bushra, A. [3 ]
Nadeem, M. [3 ]
Zakalik, K. [1 ,3 ]
Teter, B. [1 ]
Weinstock-Guttman, B. [1 ,2 ,3 ]
机构：
[1] New York State Multiple Sclerosis Consortium, Buffalo, NY USA
[2] SUNY Buffalo, Neurol, Buffalo, NY USA
[3] Jacobs MS Ctr Treatment & Res, Buffalo, NY USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1806
引用
收藏
页码：953 / 954
页数：2
相关论文
共 50 条
  • [31] Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
    Rudick, RA
    Stuart, WH
    Calabresi, PA
    Confavreux, C
    Galetta, SL
    Radue, EW
    Lublin, FD
    Weinstock-Guttman, B
    Wynn, DR
    Lynn, F
    Panzara, MA
    Sandrock, AW
    Fazekas, F
    Enzinger, C
    Seifert, T
    Storch, M
    Strasser-Fuchs, S
    Berger, T
    Dilitz, E
    Egg, R
    Deisenhammer, F
    Decoo, D
    Lampaert, J
    Bartholome, E
    Bier, J
    Stenager, E
    Rasmussen, M
    Binzer, M
    Shorsh, K
    Christensen, M
    Ravnborg, M
    Sorensen, PS
    Blinkenberg, M
    Petersen, B
    Hansen, HJ
    Bech, E
    Petersen, T
    Kirkegaard, M
    Eralinna, J
    Ruutiainen, J
    Soilu-Hänninen, M
    Säkö, E
    Laaksonen, M
    Reunanen, M
    Remes, A
    Keskinarkaus, I
    Moreau, T
    Noblet, M
    Rouaud, O
    Couvreur, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09): : 911 - 923
  • [32] Depression in multiple sclerosis associated with interferon beta-1a (Rebif)
    Pandya, R
    Patten, S
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2002, 47 (07): : 686 - 686
  • [33] Peginterferon beta-1a for the treatment of relapsing multiple sclerosis: A case series
    Hendin, Barry A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 26 : 33 - 36
  • [34] AUtoimmunity PRofile in INterferon beta-1a treated multiple sclerosis patients. The AUPRIN Study: Comparison of 2 different dosages of subcutaneous interferon beta-1a
    Verdun, E
    Giordano, L
    Cucci, MA
    Ricci, A
    Barbero, P
    Pipieri, A
    Clerico, M
    Aimo, G
    Durelli, L
    NEUROLOGY, 2005, 64 (06) : A384 - A385
  • [35] Glatiramer acetate versus interferon Beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients
    Jane Castelli-Haley
    MerryKay A. Oleen-Burkey
    Maureen J. Lage
    Kenneth P. Johnson
    Advances in Therapy, 2008, 25 (8) : 830 - 830
  • [36] Glatiramer acetate versus interferon beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients
    Jane Castelli-Haley
    Merry-Kay A. Oleen-Burkey
    Maureen J. Lage
    Kenneth P. Johnson
    Advances in Therapy, 2008, 25 : 658 - 673
  • [37] Acute hepatitis secondary to interferon beta-1a in multiple sclerosis
    Christopher, V
    Scolding, N
    Przemioslo, R
    JOURNAL OF NEUROLOGY, 2005, 252 (07) : 855 - 856
  • [38] Desensitization to interferon BETA-1A (IFB) in a patient with multiple sclerosis
    Strub, P
    Austin, EJ
    German, D
    White, T
    Serwonska, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S38 - S38
  • [39] Interferon beta-1a in children with multiple sclerosis is well tolerated
    Waubant, E
    Hietpas, J
    Stewart, T
    Dyme, Z
    Herbert, J
    Lacy, J
    Miller, C
    Rensel, M
    Schwid, S
    Goodkin, D
    NEUROPEDIATRICS, 2001, 32 (04) : 211 - 213
  • [40] Development of an electronic injection device for subcutaneous interferon beta-1a administration in patients with relapsing multiple sclerosis
    Exell, S.
    Verdun, E.
    Driebergen, R.
    Migliaccio, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S203 - S203
12345